Knutsen, Helle KatrineBarregård, LarsBignami, MargheritaBrüschweiler, BeatCeccatelli, SandraCottrill, BruceDinovi, MichaelEdler, LutzGrasl-Kraupp, BettinaHogstrand, ChristerHoogenboom, Laurentius (Ron)Nebbia, Carlo StefanoOswald, Isabelle PPetersen, AnnetteRose, MartinRoudot, Alain-ClaudeSchwerdtle, TanjaVleminckx, ChristianeVollmer, GünterWallace, HeatherDall'Asta, ChiaraGutleb, Arno CMetzler, ManfredParent-Massin, DominiqueBinaglia, MarcoSteinkellner, HansAlexander, JanEFSA Panel on Contaminants in the Food Chain (CONTAM)2018-08-302018-08-302017-04Knutsen, H K, Barregård, L, Bignami, M, Brüschweiler, B, Ceccatelli, S, Cottrill, B, Dinovi, M, Edler, L, Grasl-Kraupp, B, Hogstrand, C, Hoogenboom, L, Nebbia, C S, Oswald, I P, Petersen, A, Rose, M, Roudot, A-C, Schwerdtle, T, Vleminckx, C, Vollmer, G, Wallace, H, Dall'Asta, C, Gutleb, A C, Metzler, M, Parent-Massin, D, Binaglia, M, Steinkellner, H, Alexander, J & EFSA Panel on Contaminants in the Food Chain (CONTAM) 2017, 'Appropriateness to set a group health based guidance value for nivalenol and its modified forms', EFSA Journal, vol. 15, no. 4, e04751. https://doi.org/10.2903/j.efsa.2017.47511831-4732RIS: urn:6F82A9F4C223A4CAE10B04B8F675A1B2http://hdl.handle.net/2164/11007The Panel wishes to thank the members of the Working Group on HBGV for mycotoxins and their modified forms: Jan Alexander, Chiara Dall'Asta, Arno Gutleb, Manfred Metzler, Isabelle P Oswald and Dominique Parent‐Massin for the preparatory work on this scientific output, and the EFSA staff members: Marco Binaglia and Hans Steinkellner for the support provided to this scientific output. Adopted: 15 March 2017251760700engnivalenolmodified formsgroup health based guidance valueR Medicine (General)R1Journal article10.2903/j.efsa.2017.4751154